Matsuda Hiromi, Toda Masaya, Kosaka Yasuharu, Arai Masayasu, Okamoto Hirotsugu
Masui. 2014 Apr;63(4):446-50.
It is known that acute liver dysfunction is one of the complications after Fontan operation. We tend to overlook it because their laboratory abnormalities are typically mild and hepatic dysfunction is an uncommon complication in children after cardiac surgery. However, this complication is likely to be an important indicator of poor prognosis. We report a patient who showed a prominent elevation of liver enzymes after Fontan operation. A year and 5 month old boy was scheduled for Fontan operation due to hypoplastic left heart syndrome. We used arterial pressure, central venous pressure and rSO2 probes (INVOS 5100, Somanetics Corp., USA) attaching on his head, abdomen and leg for circulatory management. The operation was performed with the heart beating. The blood removal tubes were inserted to the superior vena cava and inferior vena cava and the blood sending tube was inserted to the innominate artery when Norwood stage 1 was performed. After making an extracardiac conduit and a fenestration, we tried to take off the oxygenator with dopamine 5 microg x kg(-1) x min(-1), dobutamine 3 microg x kg(-1) x min(-1), isosorbide 2.5 microg x kg(-1) x min(-1). The central venous pressure was increased to 22-25 mmHg and systematic arterial pressure was unstable around 50 mmHg. We suggested the surgeons to expand the fenestration because the low flow through it was found on TEE examination, and introduced 15 ppm of nitric monoxide (NO) to decrease pulmonary vascular resistance and to control the central venous pressure at the same time. rSO2 was decreased to 50 temporarily when the oxygenator was taken off, however it was returned to 70 just after expanding the fenestration. On the first postoperative day, the patient showed marked elevations in GOT 17,305 U x l(-1), GPT 8,110 U x l(-1), gradually peaking out to GOT 105 U x l(-1), GPT 1,348 U x l(-1) by the seventh postoperative day. Hepatic dysfunction is related mainly to hemodynamic disturbances and is also related to the abdominal rSO2 and the high central venous pressure.
众所周知,急性肝功能障碍是Fontan手术后的并发症之一。我们往往会忽视它,因为其实验室检查异常通常较轻,且肝功能障碍在儿童心脏手术后是一种不常见的并发症。然而,这种并发症可能是预后不良的重要指标。我们报告了一名Fontan手术后肝酶显著升高的患者。一名1岁5个月大的男孩因左心发育不全综合征计划接受Fontan手术。我们使用动脉压、中心静脉压和rSO2探头(INVOS 5100,美国索曼etics公司)分别附着在他的头部、腹部和腿部进行循环管理。手术在心脏跳动的情况下进行。在进行Norwood一期手术时,将采血导管插入上腔静脉和下腔静脉,将输血导管插入无名动脉。在制作心外管道和开窗后,我们尝试在多巴胺5微克·千克⁻¹·分钟⁻¹、多巴酚丁胺3微克·千克⁻¹·分钟⁻¹、异山梨醇2.5微克·千克⁻¹·分钟⁻¹的情况下撤掉体外循环机。中心静脉压升至22 - 25 mmHg,系统动脉压在50 mmHg左右不稳定。经TEE检查发现通过开窗的血流量较低,我们建议外科医生扩大开窗,并引入15 ppm的一氧化氮(NO)以降低肺血管阻力并同时控制中心静脉压。撤掉体外循环机时rSO2暂时降至50,但在扩大开窗后立即恢复到70。术后第一天,患者的谷草转氨酶(GOT)升至17305 U·升⁻¹,谷丙转氨酶(GPT)升至8110 U·升⁻¹,到术后第七天逐渐峰值降至GOT 105 U·升⁻¹,GPT 1348 U·升⁻¹。肝功能障碍主要与血流动力学紊乱有关,也与腹部rSO2和高中心静脉压有关。